Keytruda Qlex J Code: J9277

Drug & Product Overview

HCPCS Descriptor Injection, pembrolizumab, 1 mg and berahyaluronidase alfa-pmph

HCPCS Added Date April 1, 2026

Manufacturer Merck Sharp & Dohme Corp

Route of Administration Subcutaneous

Generic Status Single-Source; Branded

Dosage Form Injection, Solution

About Keytruda Qlex

Keytruda Qlex is a medication aligned to the HCPCS J Code: J9277 for billing, pricing, and reimbursement purposes in the United States. It is an Oncology drug administered via the subcutaneous route and manufactured by Merck Sharp & Dohme Corp.

Manufacturers, reach out to us to add more information.

NDC Code Information

Based on publicly available CMS files. Showing 2 of 4 NDCs — log in for the full crosswalk.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
00006-3083-01	Keytruda Qlex	Merck Sharp & Dohme LLC	395	396 MG / 2.4 ML
00006-5083-01	Keytruda Qlex	Merck Sharp & Dohme LLC	790	792 MG / 4.8 ML
•••••-••••-•• Log in to view	Keytruda Qlex
	Keytruda Qlex

Login to view 2 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

Keytruda Qlex Pricing & Reimbursement

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q3 2026

Keytruda Qlex Claims Performance

Claims from Jan 2026 – Aug 2026

Claim Denial Rate 26.42%

Avg. Days to File 5.8days

Avg. Days to Pay 25.8days

Real-world claims performance from FocalPoint, OnPoint Oncology's reimbursement analytics platform, with claims data accrued at the clearing house level.

Explore J9277 claims analytics on FocalPoint →

Keytruda Qlex CPT Administration Codes

CPT Code	Description
96401	Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic

Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

Keytruda Qlex Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Biliary Tract Cancer Cervical Cancer Cutaneous Squamous Cell Carcinoma Endometrial Carcinoma Esophageal Cancer Gastric Cancer Head and Neck Squamous Cell Cancer Hepatocellular Carcinoma MSI-H or dMMR Colorectal Cancer MSI-H or dMMR Solid Tumors Malignant Pleural Mesothelioma Melanoma Merkel Cell Carcinoma Muscle Invasive Bladder Cancer Non-Muscle Invasive Bladder Cancer Non-Small Cell Lung Cancer Ovarian Cancer Renal Cell Carcinoma Triple-Negative Breast Cancer Tumor Mutational Burden-High Cancer Urothelial Cancer Urothelial Carcinoma

Show all 22 conditions Show fewer

Drug Class

Endoglycosidase [EPC]Glycoside Hydrolases [CS]Programmed Death Receptor-1 Blocking Antibody [EPC]Programmed Death Receptor-1-directed Antibody Interactions [MoA]

Frequently Asked Questions

Is there an available Keytruda Qlex billing and coding guide?

Billing and coding information for Keytruda Qlex can be found through Merck Sharp & Dohme LLC. Visit Here →

Are there any available Keytruda Qlex patient assistance programs?

Keytruda Qlex patient assistance information can be found through Merck Sharp & Dohme LLC. Visit Here →

Where can I find Keytruda Qlex prescribing information?

Keytruda Qlex prescribing information can be found at the link below. Visit Here →

Where can I find Keytruda Qlex side effect information?

Information regarding Keytruda Qlex's side effects can be found at MedlinePlus. Visit Here →

Does billing Keytruda Qlex require JZ/JW wastage modifiers?

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.